{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:32:52Z","timestamp":1791433972245,"version":"4.3.3"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:00:00Z","timestamp":1634169600000},"content-version":"am","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.actbio.2020.08.013","type":"journal-article","created":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T17:38:10Z","timestamp":1597599490000},"page":"149-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Steroid-eluting contact lenses for corneal and intraocular inflammation"],"prefix":"10.1016","volume":"116","author":[{"given":"Lokendrakumar C.","family":"Bengani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenaga","family":"Kobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualei","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja","family":"Salvador-Culla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Tulsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi E.","family":"Kolovou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad K.","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil K.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Kohane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph B.","family":"Ciolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.actbio.2020.08.013_bib0001","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"12","author":"Chang","year":"2001","journal-title":"Current Opin. Ophthalmol."},{"issue":"12","key":"10.1016\/j.actbio.2020.08.013_bib0002","first-page":"42","article-title":"Uveitis: pathogenesis, clinical presentations and treatment","volume":"4","author":"Mustafa","year":"2014","journal-title":"IOSR J. Pharmacy"},{"key":"10.1016\/j.actbio.2020.08.013_bib0003","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/OPTO.S72079","article-title":"Diagnosis and treatment of anterior uveitis: optometric management","volume":"8","author":"Harthan","year":"2016","journal-title":"Clin. Optometry"},{"key":"10.1016\/j.actbio.2020.08.013_bib0004","first-page":"1","article-title":"Literature review and suggested protocol for prevention and treatment of corneal graft rejection","author":"Magalhaes","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.actbio.2020.08.013_bib0005","first-page":"264","article-title":"Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)","volume":"104","author":"Azar","year":"2006","journal-title":"Trans. Am. Ophthalmol. Soc."},{"issue":"6","key":"10.1016\/j.actbio.2020.08.013_bib0006","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00003226-199511000-00014","article-title":"Corneal neovascularization after penetrating keratoplasty","volume":"14","author":"Dana","year":"1995","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.actbio.2020.08.013_bib0007","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1076\/ocii.10.4.263.15592","article-title":"Uveitis: a global perspective","volume":"10","author":"Chang","year":"2002","journal-title":"Ocular Immunol. Inflamm."},{"issue":"4","key":"10.1016\/j.actbio.2020.08.013_bib0008","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ophtha.2011.10.016","article-title":"Efficacy and safety of long-term corticosteroid eye drops after penetrating keratoplasty: a prospective, randomized, clinical trial","volume":"119","author":"Shimazaki","year":"2012","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.actbio.2020.08.013_bib0009","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/IIO.0b013e3181924e23","article-title":"Corneal graft rejection","volume":"49","author":"Lam","year":"2009","journal-title":"Int. Ophthalmol. Clin."},{"issue":"4","key":"10.1016\/j.actbio.2020.08.013_bib0010","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3129\/i10-081","article-title":"Practical approach to the use of corticosteroids in patients with uveitis","volume":"45","author":"Cunningham","year":"2010","journal-title":"Canad. J. Ophthalmol."},{"issue":"0910","key":"10.1016\/j.actbio.2020.08.013_bib0011","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2019.20025","article-title":"Treatment of chronic non-infectious uveitis and scleritis","volume":"149","author":"Rossi","year":"2019","journal-title":"Swiss Med. Wkly."},{"issue":"12 Suppl","key":"10.1016\/j.actbio.2020.08.013_bib0012","first-page":"S215","article-title":"Innovations in topical ocular corticosteroid therapy for the management of postoperative ocular inflammation and pain","volume":"25","author":"Salinger","year":"2019","journal-title":"Am. J. Manag. Care"},{"issue":"6","key":"10.1016\/j.actbio.2020.08.013_bib0013","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.ophtha.2016.02.001","article-title":"Descemet's membrane endothelial keratoplasty: risk of immunologic rejection episodes after discontinuing topical corticosteroids","volume":"123","author":"Price","year":"2016","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.actbio.2020.08.013_bib0014","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ajo.2007.03.028","article-title":"Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty","volume":"144","author":"Nguyen","year":"2007","journal-title":"Am. J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.actbio.2020.08.013_bib0015","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/01.ico.0000240098.01468.4c","article-title":"Risk factors for the first episode of corneal graft rejection in keratoconus","volume":"25","author":"Epstein","year":"2006","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.actbio.2020.08.013_bib0016","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/IJG.0b013e31814b990d","article-title":"Barriers to glaucoma drug delivery","volume":"17","author":"Ghate","year":"2008","journal-title":"J. Glaucoma"},{"issue":"1","key":"10.1016\/j.actbio.2020.08.013_bib0017","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0169-409X(95)00010-5","article-title":"Ocular absorption following topical delivery","volume":"16","author":"J\u00e4rvinen","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.actbio.2020.08.013_bib0018","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2710.2001.00363.x","article-title":"Patient adherence to treatment: three decades of research. A comprehensive review","volume":"26","author":"Vermeire","year":"2001","journal-title":"J. Clin. Pharm. Therapeut."},{"issue":"11","key":"10.1016\/j.actbio.2020.08.013_bib0019","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1517\/17425247.2013.821462","article-title":"Contact lenses as a platform for ocular drug delivery","volume":"10","author":"Bengani","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"issue":"4","key":"10.1016\/j.actbio.2020.08.013_bib0020","first-page":"317","article-title":"Sustained release intraocular drug delivery devices for treatment of uveitis","volume":"6","author":"Haghjou","year":"2011","journal-title":"J. Ophthal. Vis. Res."},{"issue":"2","key":"10.1016\/j.actbio.2020.08.013_bib0021","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1089\/jop.2012.0241","article-title":"Anterior eye segment drug delivery systems: current treatments and future challenges","volume":"29","author":"Molokhia","year":"2013","journal-title":"J.Ocular Pharmacol. Therapeut."},{"issue":"10","key":"10.1016\/j.actbio.2020.08.013_bib0022","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s11095-010-0159-x","article-title":"Biodegradable implants for sustained drug release in the eye","volume":"27","author":"Lee","year":"2010","journal-title":"Pharmaceut. Res."},{"issue":"10","key":"10.1016\/j.actbio.2020.08.013_bib0023","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jcrs.2015.11.005","article-title":"Sustained-release dexamethasone for the treatment of ocular inflammation and pain after cataract surgery","volume":"41","author":"Walters","year":"2015","journal-title":"J. Cataract & Refract. Surg."},{"key":"10.1016\/j.actbio.2020.08.013_bib0024","first-page":"156","article-title":"Contact lenses for drug delivery, Seminars in ophthalmology","author":"Ciolino","year":"2009","journal-title":"Taylor & Francis"},{"issue":"10","key":"10.1016\/j.actbio.2020.08.013_bib0025","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4155\/tde.14.76","article-title":"Clinicians\u2019 perspectives on the use of drug-eluting contact lenses for the treatment of glaucoma","volume":"5","author":"Taniguchi","year":"2014","journal-title":"Therapeut. Deliv."},{"issue":"1","key":"10.1016\/j.actbio.2020.08.013_bib0026","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/ICL.0b013e31827d4f25","article-title":"Uptake and release phenomena in contact lens care by silicone hydrogel lenses","volume":"39","author":"Jones","year":"2013","journal-title":"Eye Contact Lens"},{"issue":"5","key":"10.1016\/j.actbio.2020.08.013_bib0027","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/archopht.1974.01010010425011","article-title":"Ocular penetration of prednisolone and the hydrophilic contact lens","volume":"92","author":"Hull","year":"1974","journal-title":"Arch. Ophthalmol."},{"issue":"3","key":"10.1016\/j.actbio.2020.08.013_bib0028","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0002-9394(72)90062-1","article-title":"Pilocarpine therapy with soft contact lenses","volume":"73","author":"Podos","year":"1972","journal-title":"Am. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.actbio.2020.08.013_bib0029","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1167\/iovs.08-2826","article-title":"A drug-eluting contact lens","volume":"50","author":"Ciolino","year":"2009","journal-title":"Investig. Ophthalmol. Visual sci."},{"issue":"9","key":"10.1016\/j.actbio.2020.08.013_bib0030","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1167\/iovs.10-6935","article-title":"A prototype antifungal contact lens","volume":"52","author":"Ciolino","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.actbio.2020.08.013_bib0031","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.biomaterials.2013.09.032","article-title":"In vivo performance of a drug-eluting contact lens to treat glaucoma for a month","volume":"35","author":"Ciolino","year":"2014","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.actbio.2020.08.013_bib0032","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.ophtha.2016.06.038","article-title":"Latanoprost-eluting contact lenses in glaucomatous monkeys","volume":"123","author":"Ciolino","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.actbio.2020.08.013_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119285","article-title":"Topical sustained drug delivery to the retina with a drug-eluting contact lens","author":"Ross","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2020.08.013_bib0034","article-title":"A review of international medical device regulations: Contact lenses and lens care solutions","author":"Zaki","year":"2018","journal-title":"Contact Lens Anterior Eye"},{"issue":"6","key":"10.1016\/j.actbio.2020.08.013_bib0035","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0039-6257(01)00211-9","article-title":"The Draize eye test","volume":"45","author":"Wilhelmus","year":"2001","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.actbio.2020.08.013_bib0036","series-title":"Test 405: Acute Eye Irritation\/Corrosion, OECD Guidelines for the Testing of Chemicals","article-title":"Organisation for Economic and Cooperative Development","year":"2012"},{"issue":"3","key":"10.1016\/j.actbio.2020.08.013_bib0037","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/ICO.0b013e31815cf67d","article-title":"Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin)","volume":"27","author":"Kim","year":"2008","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.actbio.2020.08.013_bib0038","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ajo.2010.04.024","article-title":"Inhibition of corneal neovascularization by topical bevacizumab (anti-VEGF) and sunitinib (anti-VEGF and anti-PDGF) in an animal model","volume":"150","author":"P\u00e9rez-Santonja","year":"2010","journal-title":"Am. J. Ophthalmol."},{"issue":"12","key":"10.1016\/j.actbio.2020.08.013_bib0039","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/ICO.0b013e31821c9b5a","article-title":"Therapeutic efficacy of topical epigallocatechin gallate (EGCG) in murine dry eye","volume":"30","author":"Lee","year":"2011","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.actbio.2020.08.013_bib0040","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1167\/iovs.17-23067","article-title":"Mesenchymal stromal cells inhibit neutrophil effector functions in a murine model of ocular inflammation","volume":"59","author":"Mittal","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.actbio.2020.08.013_bib0041","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/stem.2611","article-title":"Mesenchymal stem cells modulate differentiation of myeloid progenitor cells during inflammation","volume":"35","author":"Amouzegar","year":"2017","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.actbio.2020.08.013_bib0042","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/TP.0000000000001044","article-title":"In vivo expansion of regulatory T cells by low-dose interleukin-2 treatment increases allograft survival in corneal transplantation","volume":"100","author":"Tahvildari","year":"2016","journal-title":"Transplantation"},{"issue":"1-2","key":"10.1016\/j.actbio.2020.08.013_bib0043","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.vetimm.2007.06.024","article-title":"Use of flow cytometry to identify monoclonal antibodies that recognize conserved epitopes on orthologous leukocyte differentiation antigens in goats, lamas, and rabbits","volume":"119","author":"Davis","year":"2007","journal-title":"Veterinary Immunol. Immunopathol."},{"issue":"4","key":"10.1016\/j.actbio.2020.08.013_bib0044","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jtos.2019.07.005","article-title":"Therapeutic efficacy of different routes of mesenchymal stem cell administration in corneal injury","volume":"17","author":"Shukla","year":"2019","journal-title":"The Ocular Surf."},{"issue":"10","key":"10.1016\/j.actbio.2020.08.013_bib0045","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/sctm.19-0004","article-title":"Mesenchymal stromal cells modulate corneal alloimmunity via secretion of hepatocyte growth factor","volume":"8","author":"Mittal","year":"2019","journal-title":"Stem Cells Transl. Med."},{"issue":"4","key":"10.1016\/j.actbio.2020.08.013_bib0046","first-page":"221","article-title":"Report of the National Eye Institute\/Industry workshop on clinical trials in dry eyes","volume":"21","author":"Lemp","year":"1995","journal-title":"Eye & Contact Lens"},{"key":"10.1016\/j.actbio.2020.08.013_bib0047","unstructured":"ISO, ISO 10993-1:2018 Biological evaluation of medical devices \u2013 Part 1: Evaluation and testing within a risk management process. https:\/\/www.iso.org\/standard\/68936.html. (Accessed 30th May 2019."},{"key":"10.1016\/j.actbio.2020.08.013_bib0048","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.biopha.2017.09.124","article-title":"Local anaesthetic pain relief therapy: in vitro and in vivo evaluation of a nanotechnological formulation co-loaded with ropivacaine and dexamethasone","volume":"96","author":"Zhang","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.actbio.2020.08.013_bib0049","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1083\/jcb.96.2.577","article-title":"Dexamethasone induces gelsolin synthesis and altered morphology in L929 cells","volume":"96","author":"Lanks","year":"1983","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.actbio.2020.08.013_bib0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/IJN.S6428","article-title":"Pharmacokinetics and tolerance study of intravitreal injection of dexamethasone-loaded nanoparticles in rabbits","volume":"4","author":"Zhang","year":"2009","journal-title":"Int. J. Nanomed."},{"issue":"9","key":"10.1016\/j.actbio.2020.08.013_bib0051","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/archopht.1989.01070020445052","article-title":"Collagen shield enhancement of topical dexamethasone penetration","volume":"107","author":"Hwang","year":"1989","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.actbio.2020.08.013_bib0052","first-page":"161","article-title":"Ophthalmic delivery system for dexamethasone: an overview","volume":"2","author":"Suresh","year":"2011","journal-title":"Int. J. Innov. Pharm. Res."},{"key":"10.1016\/j.actbio.2020.08.013_bib0053","doi-asserted-by":"crossref","DOI":"10.1097\/00005053-197611000-00003","article-title":"On the methods and theory of reliability","author":"Bartko","year":"1976","journal-title":"J. Nervous Mental Dis."},{"issue":"1","key":"10.1016\/j.actbio.2020.08.013_bib0054","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1037\/1082-989X.1.1.30","article-title":"Forming inferences about some intraclass correlation coefficients","volume":"1","author":"McGraw","year":"1996","journal-title":"Psychol. Methods"},{"issue":"2","key":"10.1016\/j.actbio.2020.08.013_bib0055","first-page":"218","article-title":"Corneal swelling response to contact lenses worn under extended wear conditions","volume":"24","author":"Holden","year":"1983","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.actbio.2020.08.013_bib0056","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00003226-199103000-00006","article-title":"Corneal edema after overnight lid closure of rabbits wearing silicone rubber contact lenses","volume":"10","author":"Koch","year":"1991","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.actbio.2020.08.013_bib0057","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.optom.2014.03.002","article-title":"Overnight corneal swelling with high and low powered silicone hydrogel lenses","volume":"8","author":"Moezzi","year":"2015","journal-title":"J. Optometry"},{"issue":"11","key":"10.1016\/j.actbio.2020.08.013_bib0058","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/00006324-200111000-00008","article-title":"Effects of contact lens-induced hypoxia on the physiology of the corneal endothelium","volume":"78","author":"Bonanno","year":"2001","journal-title":"Optometry Vis. Sci."},{"issue":"11","key":"10.1016\/j.actbio.2020.08.013_bib0059","doi-asserted-by":"crossref","first-page":"TFOS98","DOI":"10.1167\/iovs.13-13187","article-title":"The TFOS International Workshop on Contact Lens Discomfort: report of the contact lens interactions with the ocular surface and adnexa subcommittee","volume":"54","author":"Efron","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.actbio.2020.08.013_bib0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/jop.1987.3.185","article-title":"Steroid-induced ocular hypertension in the rabbit: a model using subconjunctival injections","volume":"3","author":"Hester","year":"1987","journal-title":"J. Ocular Pharmacol. Therapeut."},{"issue":"9","key":"10.1016\/j.actbio.2020.08.013_bib0061","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/bjo.63.9.646","article-title":"Ocular changes in rabbits with corticosteroid-induced ocular hypertension","volume":"63","author":"Ticho","year":"1979","journal-title":"Br. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.actbio.2020.08.013_bib0062","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0021-5155(00)00209-4","article-title":"A case of noninflammatory corneal edema following anterior-posterior radial keratotomy (Sato's operation) successfully treated by topical corticosteroid","volume":"44","author":"Fukuda","year":"2000","journal-title":"Japn. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.actbio.2020.08.013_bib0063","article-title":"Effect of a soluble epoxide hydrolase inhibitor, UC1728, on LPS-induced uveitis in the rabbit","volume":"4","author":"McLellan","year":"2016","journal-title":"J. ocular biology"},{"issue":"7","key":"10.1016\/j.actbio.2020.08.013_bib0064","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.ophtha.2012.04.004","article-title":"Rabbit intraocular reactivity to endotoxin measured by slit-lamp biomicroscopy and laser flare photometry","volume":"119","author":"Nussenblatt","year":"2012","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.actbio.2020.08.013_bib0065","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1016\/j.ophtha.2012.04.006","article-title":"Rabbit ocular reactivity to bacterial endotoxin contained in aqueous solution and ophthalmic viscosurgical devices","volume":"119","author":"Buchen","year":"2012","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.actbio.2020.08.013_bib0066","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archophthalmol.2011.42","article-title":"Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids","volume":"129","author":"Hos","year":"2011","journal-title":"Arch. Ophthalmol."},{"issue":"3","key":"10.1016\/j.actbio.2020.08.013_bib0067","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2353\/ajpath.2007.070172","article-title":"Dexamethasone inhibits interleukin-1\u03b2-induced corneal neovascularization: role of nuclear factor-\u03baB-activated stromal cells in inflammatory angiogenesis","volume":"171","author":"Nakao","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.actbio.2020.08.013_bib0068","first-page":"119","article-title":"Controlled release of dexamethasone sodium phosphate with biodegradable nanoparticles for preventing experimental corneal neovascularization, Nanomedicine: Nanotechnology","volume":"17","author":"Wang","year":"2019","journal-title":"Biol. Med."},{"issue":"2","key":"10.1016\/j.actbio.2020.08.013_bib0069","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1021\/nn506599f","article-title":"Ocular drug delivery nanowafer with enhanced therapeutic efficacy","volume":"9","author":"Yuan","year":"2015","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.actbio.2020.08.013_bib0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41536-018-0061-4","article-title":"Sustained release of decorin to the surface of the eye enables scarless corneal regeneration","volume":"3","author":"Hill","year":"2018","journal-title":"NPJ Regener. Med."},{"issue":"3","key":"10.1016\/j.actbio.2020.08.013_bib0071","first-page":"267","article-title":"Rabbit models of ocular diseases: new relevance for classical approaches","volume":"15","author":"Zernii","year":"2016","journal-title":"CNS & Neurol. Disord. Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders)"},{"issue":"1","key":"10.1016\/j.actbio.2020.08.013_bib0072","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0192623307310955","article-title":"Safety evaluation of ocular drug delivery formulations: techniques and practical considerations","volume":"36","author":"Short","year":"2008","journal-title":"Toxicol. Pathol."},{"issue":"6","key":"10.1016\/j.actbio.2020.08.013_bib0073","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1167\/iovs.10-5939","article-title":"Treatment of experimental anterior and intermediate uveitis by a dexamethasone intravitreal implant","volume":"52","author":"Ghosn","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.actbio.2020.08.013_bib0074","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ophtha.2013.06.033","article-title":"Dexamethasone implant anterior chamber migration: risk factors, complications, and management strategies","volume":"121","author":"Khurana","year":"2014","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.actbio.2020.08.013_bib0075","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/ICU.0000000000000365","article-title":"Anterior segment migration of dexamethasone implant: risk factors, complications, and management","volume":"28","author":"Rahimy","year":"2017","journal-title":"Current Opin. Ophthalmol."},{"issue":"7","key":"10.1016\/j.actbio.2020.08.013_bib0076","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/IAE.0000000000001369","article-title":"Safety of intravitreal dexamethasone implant (Ozurdex): the SAFODEX study. Incidence and risk factors of ocular hypertension","volume":"37","author":"Malcl\u00e8s","year":"2017","journal-title":"Retina"},{"issue":"10","key":"10.1016\/j.actbio.2020.08.013_bib0077","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1089\/jop.2017.0053","article-title":"Noninvasive ocular drug delivery system of dexamethasone sodium phosphate in the treatment of experimental uveitis rabbit","volume":"33","author":"Papangkorn","year":"2017","journal-title":"J. Ocular Pharmacol. Therap."},{"issue":"4","key":"10.1016\/j.actbio.2020.08.013_bib0078","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s002280050635","article-title":"Improved penetration of aminoglycosides and fluoroquinolones into the aqueous humour of patients by means of Acuvue contact lenses","volume":"55","author":"Hehl","year":"1999","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.actbio.2020.08.013_bib0079","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1021\/ie0507934","article-title":"Modeling ophthalmic drug delivery by soaked contact lenses","volume":"45","author":"Li","year":"2006","journal-title":"Indus. Eng. Chem. Res."},{"issue":"12","key":"10.1016\/j.actbio.2020.08.013_bib0080","first-page":"2813","article-title":"Tear exchange under hydrogel contact lenses: methodological considerations","volume":"42","author":"Paugh","year":"2001","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.actbio.2020.08.013_bib0081","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/01.opx.0000249978.07340.b2","article-title":"Scalloped channels enhance tear mixing under hydrogel contact lenses","volume":"83","author":"Lin","year":"2006","journal-title":"Optometry Vis. Sci."},{"key":"10.1016\/j.actbio.2020.08.013_bib0082","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2015.01.023","article-title":"Sustained drug release by contact lenses for glaucoma treatment\u2014a review","volume":"202","author":"Carvalho","year":"2015","journal-title":"J. Controlled Release"},{"issue":"1-2","key":"10.1016\/j.actbio.2020.08.013_bib0083","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0378-5173(03)00124-8","article-title":"In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials","volume":"257","author":"Karlgard","year":"2003","journal-title":"Int. J. Pharmaceut."},{"issue":"1","key":"10.1016\/j.actbio.2020.08.013_bib0084","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1076\/ceyr.23.1.1.5422","article-title":"Corneal epithelial VEGF and cytochrome P450 4B1 expression in a rabbit model of closed eye contact lens wear","volume":"23","author":"Mastyugin","year":"2001","journal-title":"Current Eye Res."},{"issue":"5","key":"10.1016\/j.actbio.2020.08.013_bib0085","first-page":"828","article-title":"A closed eye contact lens model of corneal inflammation. Part 1: Increased synthesis of cytochrome P450 arachidonic acid metabolites","volume":"36","author":"Conners","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.actbio.2020.08.013_bib0086","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.survophthal.2017.10.006","article-title":"Gene-based antiangiogenic applications for corneal neovascularization","volume":"63","author":"Liu","year":"2018","journal-title":"Surv. Ophthalmol."},{"issue":"3","key":"10.1016\/j.actbio.2020.08.013_bib0087","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/ICL.0b013e31815788d7","article-title":"Rabbit models of contact lens\u2013associated corneal hypoxia: a review of the literature","volume":"34","author":"McCanna","year":"2008","journal-title":"Eye Contact Lens"},{"issue":"10","key":"10.1016\/j.actbio.2020.08.013_bib0088","first-page":"2003","article-title":"Corneal edema recovery dynamics in the rabbit. A useful model?","volume":"31","author":"Herse","year":"1990","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.actbio.2020.08.013_bib0089","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/archopht.1968.03850040368003","article-title":"Corneal thickness after topical corticosteroid therapy","volume":"79","author":"Baum","year":"1968","journal-title":"Arch. Ophthalmol."},{"issue":"2","key":"10.1016\/j.actbio.2020.08.013_bib0090","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0014-4835(70)80042-2","article-title":"Effect of topical application of hydrocortisone on the corneal thickness","volume":"10","author":"Hara","year":"1970","journal-title":"Exp. Eye Res."},{"issue":"5","key":"10.1016\/j.actbio.2020.08.013_bib0091","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF01739643","article-title":"Effect of corticosteroids on healing of the corneal endothelium in cats","volume":"235","author":"Solomon","year":"1997","journal-title":"Graefe's Arch. Clin. Exp. Ophthalmol."},{"issue":"3","key":"10.1016\/j.actbio.2020.08.013_bib0092","first-page":"357","article-title":"Effect of dexamethasone on corneal endothelial function in Fuchs' dystrophy","volume":"29","author":"Wilson","year":"1988","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.actbio.2020.08.013_bib0093","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1172\/JCI110138","article-title":"Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats","volume":"67","author":"Nussenblatt","year":"1981","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.actbio.2020.08.013_bib0094","first-page":"442","article-title":"Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis","volume":"36","author":"Cheng","year":"1995","journal-title":"Investig. Ophthalmol. Vis. Sci."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706120304736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706120304736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:31:00Z","timestamp":1761672660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706120304736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":94,"alternative-id":["S1742706120304736"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2020.08.013","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Steroid-eluting contact lenses for corneal and intraocular inflammation","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2020.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd on behalf of Acta Materialia Inc.","name":"copyright","label":"Copyright"}]}}